Finance

Beta
Lists
BFRI:NASDAQ
Biofrontera Inc
$0.94
-6.03%
(-0.060) 1D
$0.97
+3.50% (+0.033)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BFRI...
Open
$0.99
High
$1.00
Low
$0.92
Mkt. cap
11.97M
Avg. vol.
225.02K
Volume
205.52K
52-wk high
$1.19
52-wk low
$0.55
EPS
-$1.11
Beta
0.83
Shares outstanding
12.80M
No. of employees
89
Open
$0.99
High
$1.00
Low
$0.92
Mkt. cap
11.97M
Avg. vol.
225.02K
Volume
205.52K
52-wk high
$1.19
52-wk low
$0.55
EPS
-$1.11
Beta
0.83
Shares outstanding
12.80M
No. of employees
89
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to BFRI in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for BFRI in the last 3 months.
Highest
Current $0.94
$9.00 (+862.57%)
Average
$6.00 (+541.71%)
Lowest
$3.00 (+220.86%)
News stories
From sources across the web
About Biofrontera Inc
CEO-
Employees89
Founded2015
HeadquartersWoburn, Massachusetts, United States
SectorPharmaceutical industry
Websitebiofrontera-us.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
9.03M
6.99M
17.10M
10.08M
Cost of goods sold
2.64M
2.04M
3.01M
2.12M
Cost of revenue
2.64M
2.04M
3.01M
2.12M
Research and development expenses
870.00K
854.00K
787.00K
900.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.60M
10.37M
8.74M
11.00M
Operating expense
11.47M
11.22M
9.53M
11.90M
Total operating expenses
14.11M
13.27M
12.54M
14.01M
Operating income
-5.08M
-6.28M
4.56M
-3.93M
Other non operating income
-111.00K
-255.00K
503.00K
-307.00K
EBT including unusual items
-5.30M
-6.64M
5.64M
-4.75M
EBT excluding unusual items
-5.30M
-6.64M
4.94M
-4.36M
Income tax expense
21.00K
6.00K
-
-
Effective tax rate
-0.40%
-0.09%
-
-
Other operating expenses
-
-
-
-
Net income
-5.32M
-6.65M
5.64M
-4.75M
Net profit margin
-58.96%
-95.15%
32.98%
-47.12%
Earnings per share
-0.57
-0.57
0.50
-0.41
Interest and investment income
-
-
-
-
Interest expense
-115.00K
-111.00K
-121.00K
-125.00K
Net interest expenses
-115.00K
-111.00K
-121.00K
-125.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.05M
-6.26M
4.62M
-3.87M
Gain or loss from assets sale
-
-
-700.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer